{"title":"[New drugs for horses and production animals in 2024].","authors":"Christin Jana Kamutzki, Ilka Ute Emmerich","doi":"10.1055/a-2559-5769","DOIUrl":null,"url":null,"abstract":"<p><p>In 2024, there was no release of a novel pharmaceutical agent for horses and food-producing animals or an extension of existing active ingredients to other animal species on the German veterinary medicinal products market. Formic acid is now available for a new form of treatment, the short-term treatment of honeybees, and clenbuterol is available in a new dosage form, as an oral solution for horses. In the field of immunological veterinary medicinal products, three new vaccines were launched on the German veterinary medicinal products market. For the first time, a vaccine against <i>Cryptosporidium parvum</i> in cattle, against <i>Mycoplasma bovis</i> also in cattle and against the H9 subtype of avian influenza in chicken are available. For pigs, a new vaccine with a known pathogen combination with type 2d of porcine circovirus, a new miscibility and needle-free application of products against respiratory pathogens and a new combination with serovar 11 in addition to serovars 2 and 9 of <i>Actinobacillus pleuropneumoniae</i> were approved. Furthermore, a new trivalent combination of three known vaccine antigens and a new miscibility of two products against diarrheal pathogens are available for pigs. A new recombinant combination product against infectious bursitis, infectious laryngotracheitis and Marek's disease has been approved for chicken. New administration methods were introduced to the market for a vaccine against bovine coronavirus (nasal) in cattle and porcine circovirus and <i>Mycoplasma hyopneumoniae</i> (needleless) in pigs.</p>","PeriodicalId":23115,"journal":{"name":"Tieraerztliche Praxis Ausgabe Grosstiere Nutztiere","volume":"53 2","pages":"120-131"},"PeriodicalIF":0.4000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tieraerztliche Praxis Ausgabe Grosstiere Nutztiere","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1055/a-2559-5769","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/15 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
In 2024, there was no release of a novel pharmaceutical agent for horses and food-producing animals or an extension of existing active ingredients to other animal species on the German veterinary medicinal products market. Formic acid is now available for a new form of treatment, the short-term treatment of honeybees, and clenbuterol is available in a new dosage form, as an oral solution for horses. In the field of immunological veterinary medicinal products, three new vaccines were launched on the German veterinary medicinal products market. For the first time, a vaccine against Cryptosporidium parvum in cattle, against Mycoplasma bovis also in cattle and against the H9 subtype of avian influenza in chicken are available. For pigs, a new vaccine with a known pathogen combination with type 2d of porcine circovirus, a new miscibility and needle-free application of products against respiratory pathogens and a new combination with serovar 11 in addition to serovars 2 and 9 of Actinobacillus pleuropneumoniae were approved. Furthermore, a new trivalent combination of three known vaccine antigens and a new miscibility of two products against diarrheal pathogens are available for pigs. A new recombinant combination product against infectious bursitis, infectious laryngotracheitis and Marek's disease has been approved for chicken. New administration methods were introduced to the market for a vaccine against bovine coronavirus (nasal) in cattle and porcine circovirus and Mycoplasma hyopneumoniae (needleless) in pigs.
期刊介绍:
Die Tierärztliche Praxis wendet sich mit ihren beiden Reihen als einzige veterinärmedizinische Fachzeitschrift explizit an den Großtier- bzw. Kleintierpraktiker und garantiert damit eine zielgruppengenaue Ansprache. Für den Spezialisten bietet sie Original- oder Übersichtsartikel zu neuen Therapie- und Operationsverfahren oder den Einsatz moderner bildgebender Verfahren. Der weniger spezialisierte Tierarzt oder Berufseinsteiger findet auf seinen Berufsalltag zugeschnittene praxisbezogene Beiträge in der Fortbildungsrubrik „Aus Studium und Praxis“. Mit dem hervorgehobenen „Fazit für die Praxis“ am Ende jedes Artikels verschafft sich auch der eilige Leser einen raschen Überblick über die wichtigsten Inhalte dieser modern konzipierten Fachzeitschrift mit den vielen hochwertigen, überwiegend farbigen Abbildungen. In jedem Heft ermöglicht ein ATF-anerkannter Fortbildungsartikel den Erwerb einer ATF-Stunde (Akademie für tierärztliche Fortbildung).